Rossari BiotechNSE:ROSSARI -0.48%85 Net Margin % is 6.71% as of Mar. 2026, which is 6% below its 10-year median of 7.16. GuruFocus rates NSE:ROSSARI with a GF Score™ of 85/100 and a GF Value™ of ₹998.23 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,586 Chemicals companies, Rossari Biotech ranks better than 62.17% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Rossari Biotech's Net Income for the
three
months ended in Mar. 2026 was ₹460 Mil. Rossari Biotech's Revenue for the
three
months ended in Mar. 2026 was ₹6,849 Mil. Therefore, Rossari Biotech's net margin for the quarter that ended in Mar. 2026 was 6.71%.
The historical rank and industry rank for Rossari Biotech's Net Margin % or its related term are showing as below:
NSE:ROSSARI'
s Net Margin % Range Over the Past 10 Years
Min: 6.23 Med: 7.16 Max: 11.34
Current: 6.23
NSE:ROSSARI's Net Margin % is ranked better than 62.17% of 1586
companies
in the Chemicals industry
Industry Median: 3.905
vs NSE:ROSSARI: 6.23
Rossari Biotech (NSE:ROSSARI) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Rossari Biotech Net Margin % Related Terms
Rossari Biotech Net Margin % Historical Data
* Premium members only.
The historical data trend for Rossari Biotech's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ROSSARI vs LIN, SHW, ECL: Net Margin % Comparison
For the Specialty Chemicals subindustry, Rossari Biotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rossari Biotech Net Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Rossari Biotech's Net Margin % distribution charts can be found below:
* The bar in red indicates where Rossari Biotech's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rossari Biotech (NSE:ROSSARI) has a Net Margin % of 6.71% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Rossari Biotech and its competitors. This is near median its historical median of 7.16. Over the past decade, Rossari Biotech's Net Margin % has ranged from 6.23 to 11.34. According to the industry distribution chart, Rossari Biotech ranks #600 out of 1586 companies in the Chemicals industry, placing it in the top 37.8%.
Is Rossari Biotech's Net Margin % too high?
Rossari Biotech's current Net Margin % of 6.71% is near median its 10-year median of 7.16. Over the past 10 years, this metric has ranged from a low of 6.23 to a high of 11.34. The Chemicals industry median Net Margin % is 3.91. Rossari Biotech's value of 6.71% is 71.8% above this industry median. Based on the distribution chart, Rossari Biotech ranks #600 out of 1586 companies in the Chemicals industry, which is above the industry midpoint. Overall, Rossari Biotech has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's Net Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Rossari Biotech ranks #600 out of 1586 companies for Net Margin %. This puts Rossari Biotech in the upper half of its industry. The industry median Net Margin % is 3.91. Rossari Biotech's value of 6.71% is 71.8% above this benchmark. Historically, Rossari Biotech's own Net Margin % has ranged from 6.23 to 11.34 over the past decade. While the company's 10-year median is 7.16 vs. the industry median of 3.91, Rossari Biotech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Chemicals company?
The median Net Margin % among Chemicals companies is 3.91, based on 1,586 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rossari Biotech's current Net Margin % of 6.71% is 71.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Rossari Biotech and its competitors. For the Chemicals industry, the median Net Margin % is 3.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rossari Biotech's current Net Margin % is 6.71%, which is near median its own 10-year median of 7.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹998.23, compared to a current price of ₹534.85 — trading 46.4% below its estimated fair value. The current Net Margin % is 6.71%, which is near median its 10-year median of 7.16 and 71.8% above the Chemicals industry median of 3.91. Rossari Biotech's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current Net Margin % is 6.71% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?
Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued.
The current stock price of ₹534.85 is trading 46.4% below its estimated GF Value™ of ₹998.23.
GuruFocus considers Rossari Biotech to be Possible Value Trap.
Key valuation signals for NSE:ROSSARI:
Net Margin %: 6.71% (near median its 10-year median of 7.16)
GF Value™: ₹998.23 vs. price of ₹534.85 (46.4% below fair value)
Industry Position: 71.8% above the Chemicals median (#600 of 1586)
No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
85GF Score
Get the complete analysis for NSE:ROSSARI
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ROSSARI has been successfully added to your 
